↓ Skip to main content

Toremifene versus tamoxifen for advanced breast cancer

Overview of attention for article published in Cochrane database of systematic reviews, July 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (79th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
4 tweeters
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
70 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Toremifene versus tamoxifen for advanced breast cancer
Published in
Cochrane database of systematic reviews, July 2012
DOI 10.1002/14651858.cd008926.pub2
Pubmed ID
Authors

Chen Mao, Zu-Yao Yang, Ben-Fu He, Shan Liu, Jun-Hua Zhou, Rong-Cheng Luo, Qing Chen, Jin Ling Tang

Abstract

Toremifene (TOR) and tamoxifen (TAM) can both be used as treatments for advanced breast cancer.

Twitter Demographics

The data shown below were collected from the profiles of 4 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 70 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 70 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 17%
Student > Master 10 14%
Student > Bachelor 8 11%
Student > Postgraduate 5 7%
Student > Ph. D. Student 5 7%
Other 15 21%
Unknown 15 21%
Readers by discipline Count As %
Medicine and Dentistry 23 33%
Nursing and Health Professions 10 14%
Biochemistry, Genetics and Molecular Biology 7 10%
Agricultural and Biological Sciences 5 7%
Pharmacology, Toxicology and Pharmaceutical Science 3 4%
Other 6 9%
Unknown 16 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 January 2019.
All research outputs
#3,142,691
of 14,104,163 outputs
Outputs from Cochrane database of systematic reviews
#5,701
of 10,849 outputs
Outputs of similar age
#25,374
of 124,777 outputs
Outputs of similar age from Cochrane database of systematic reviews
#50
of 118 outputs
Altmetric has tracked 14,104,163 research outputs across all sources so far. Compared to these this one has done well and is in the 77th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,849 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.5. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 124,777 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 79% of its contemporaries.
We're also able to compare this research output to 118 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.